Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. From Wikipedia
Chapter 7 liquidation of its Delaware subsidiaries clears capital for a planned August NDA filing for Zaynich in support of Wockhardt’s shift toward higher-margin research-led pharmaceuticals.